Maxer completes the uploading of two clinical studies on clinical

clinicaltrialsRecently, Maxer uploaded on the platform the full data set of two pivotal studies carried out by Dompé pharmaceuticals on the drug Oxervate (cenegermin) for patients with neutrophic keratitis at stages 2 and 3.

Besides the preliminary analysis of the CSR and its appendices, the loading activity involved a delicate operation of setting and transposition of the data related to the design of each study, to their arms and the results in the three main sections of the platform: Protocol section, Document Section, and Result section. Out of this three, the one dedicated to the results is undoubtedly the most substantial and the most complex.